Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Ravuconazole is a new antifungal triazole with broad-spectrum activity and a long half-life in plasma. We studied the antifungal efficacy, safety, and pharmacokinetics of ravuconazole lysine phosphoester in escalating dosages for the treatment of invasive pulmonary aspergillosis due to Aspergillus f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Petraitiene, Ruta, Petraitis, Vidmantas, Lyman, Caron A., Groll, Andreas H., Mickiene, Diana, Peter, Joanne, Bacher, John, Roussillon, Kristin, Hemmings, Melissa, Armstrong, Derrek, Avila, Nilo A., Walsh, Thomas J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC375262/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15047519/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.4.1188-1196.2004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares